PRLD
Prelude Therapeutics Inc
Price:  
0.90 
USD
Volume:  
109,271.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRLD WACC - Weighted Average Cost of Capital

The WACC of Prelude Therapeutics Inc (PRLD) is 7.4%.

The Cost of Equity of Prelude Therapeutics Inc (PRLD) is 7.35%.
The Cost of Debt of Prelude Therapeutics Inc (PRLD) is 5.00%.

Range Selected
Cost of equity 6.30% - 8.40% 7.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 8.4% 7.4%
WACC

PRLD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.53 0.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.30% 8.40%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 8.4%
Selected WACC 7.4%